Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Health-tracking smart ring maker Oura to list on US stock market

Valuation above $11bn expected for firm whose fans include Prince Harry, Jennifer Aniston and Kim Kardashian Fans of Oura are accustomed to using its trendy smart rings to fastidiously monitor their health but now investors are preparing to track a new metric: its share price. The company’s filing to list imminently on the Nasdaq stock exchange in New York was made public on Thursday. Continue…

Health-tracking smart ring maker Oura to list on US stock market

Oura, Inc., a Finnish tech company specializing in smart rings, has filed registration papers with the Securities and Exchange Commission (SEC) for an anticipated initial public offering (IPO) on the Nasdaq stock exchange. This marks a departure from the typical high-profile tech IPOs, as Oura is a much smaller company.

Oura's flagship product is the Oura smart ring, which tracks biometric data such as heart rate, sleep patterns, and calorie burn. The company currently offers two ring models: the Oura Ring 5 and the Oura Ring 4, with the latter starting at $399. In addition to hardware sales, Oura generates revenue through software subscriptions, known as Oura Membership, which costs $5.99 per month or $69.99 per year.

As of June 30, 2026, Oura reported 5 million paid subscribers. During the nine months preceding that date, the company generated $240.5 million in membership revenue and nearly $944 million from hardware sales. The company has also become profitable, posting a net income of $60.8 million for the nine-month period.

Oura plans to list its shares under the ticker "OURA" on the Nasdaq Global Select Market. The company has not yet determined the share price for its IPO or the number of shares it intends to offer. Estimates suggest that Oura might raise up to $3 billion in its IPO, with a potential value of up to $16 billion following the offering.

Written by urgent.news from Fast Company's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at theguardian.com →

More in Finance & Markets

Cliffwater private credit fund caps redemptions again

Cliffwater’s flagship private credit fund has once again limited quarterly redemptions to 5% after investors sought to withdraw around 16% of their holdings, underscoring continued liquidity pressures…

  • Cliffwater fund limits redemptions to 5% quarterly
  • Investors sought to withdraw 16% of investments
  • CEO Stephen Nesbitt confident in private credit resilience

EQT-backed Cerba seeks French court protection

EQT-backed healthcare diagnostics group Cerba Healthcare has asked a French commercial court to open supervised restructuring proceedings as it seeks to address a debt burden of around €5bn and…

  • Cerba Healthcare seeks French court protection to restructure debt of €5bn.
  • Company aims to improve liquidity by negotiating with France’s National Health Authorities.
  • Cerba extended negotiation window with lenders, granting grace period until November.

More from Friday 4 September →